We compare a slew of factors such as historical revenue growth, returns, and valuation multiple in an interactive dashboard analysis of Abbott vs. Baxter: Which Stock Is A Better Bet? Beyond the recovery point, we apply the average annual growth observed three years before Covid to simulate a return to normal conditions. With inflation rising and the Fed raising interest rates, among other factors, ABT stock has fallen 24% this year while BAX has seen a 30% decline.